Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study.

Duration and toxicity of adjuvant trastuzumab in older patients with early-stage breast cancer: a population-based study. J Clin Oncol. 2014 Mar 20; 32(9):927-34.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.